Dose Escalation Trial of CD40.Pan.CoV Vaccine, Adjuvanted or Not, as a Booster in Adult Healthy Volunteers
Clinical trial NCT07113106 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07113106
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-18
- Primary completion
- 2026-10-08
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.